nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—CHRM3—muscle of abdomen—skin cancer	0.0644	0.303	CbGeAlD
Aclidinium—CHRM5—skin epidermis—skin cancer	0.0421	0.198	CbGeAlD
Aclidinium—Cardiac failure—Imiquimod—skin cancer	0.0216	0.0274	CcSEcCtD
Aclidinium—Urinary retention—Imiquimod—skin cancer	0.02	0.0254	CcSEcCtD
Aclidinium—Nervous system disorder—Vismodegib—skin cancer	0.0193	0.0245	CcSEcCtD
Aclidinium—Infestation NOS—Vemurafenib—skin cancer	0.019	0.0242	CcSEcCtD
Aclidinium—Infestation—Vemurafenib—skin cancer	0.019	0.0242	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Vismodegib—skin cancer	0.017	0.0215	CcSEcCtD
Aclidinium—Infestation NOS—Imiquimod—skin cancer	0.0162	0.0206	CcSEcCtD
Aclidinium—Infestation—Imiquimod—skin cancer	0.0162	0.0206	CcSEcCtD
Aclidinium—Eye disorder—Vemurafenib—skin cancer	0.016	0.0203	CcSEcCtD
Aclidinium—Mediastinal disorder—Vemurafenib—skin cancer	0.0154	0.0195	CcSEcCtD
Aclidinium—Sinusitis—Imiquimod—skin cancer	0.0152	0.0193	CcSEcCtD
Aclidinium—Rhinitis—Imiquimod—skin cancer	0.0146	0.0185	CcSEcCtD
Aclidinium—Urinary tract disorder—Imiquimod—skin cancer	0.0144	0.0183	CcSEcCtD
Aclidinium—Urethral disorder—Imiquimod—skin cancer	0.0143	0.0181	CcSEcCtD
Aclidinium—CHRM5—epithelium—skin cancer	0.0137	0.0645	CbGeAlD
Aclidinium—Eye disorder—Imiquimod—skin cancer	0.0136	0.0173	CcSEcCtD
Aclidinium—Diarrhoea—Vismodegib—skin cancer	0.0134	0.0171	CcSEcCtD
Aclidinium—Mediastinal disorder—Imiquimod—skin cancer	0.0131	0.0167	CcSEcCtD
Aclidinium—CHRM5—skin of body—skin cancer	0.013	0.0614	CbGeAlD
Aclidinium—Cough—Vemurafenib—skin cancer	0.013	0.0165	CcSEcCtD
Aclidinium—Vomiting—Vismodegib—skin cancer	0.0125	0.0159	CcSEcCtD
Aclidinium—Infection—Vemurafenib—skin cancer	0.0121	0.0153	CcSEcCtD
Aclidinium—Cardiac failure—Fluorouracil—skin cancer	0.0119	0.0151	CcSEcCtD
Aclidinium—Nervous system disorder—Vemurafenib—skin cancer	0.0119	0.0151	CcSEcCtD
Aclidinium—Osteoarthritis—Fluorouracil—skin cancer	0.0116	0.0148	CcSEcCtD
Aclidinium—Cough—Imiquimod—skin cancer	0.0111	0.0141	CcSEcCtD
Aclidinium—CHRM4—head—skin cancer	0.0109	0.0512	CbGeAlD
Aclidinium—Dry mouth—Imiquimod—skin cancer	0.0106	0.0134	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Vemurafenib—skin cancer	0.0105	0.0133	CcSEcCtD
Aclidinium—Nasopharyngitis—Fluorouracil—skin cancer	0.0104	0.0132	CcSEcCtD
Aclidinium—Infection—Imiquimod—skin cancer	0.0103	0.0131	CcSEcCtD
Aclidinium—Nervous system disorder—Imiquimod—skin cancer	0.0101	0.0129	CcSEcCtD
Aclidinium—Tachycardia—Imiquimod—skin cancer	0.0101	0.0128	CcSEcCtD
Aclidinium—Infestation NOS—Temozolomide—skin cancer	0.00972	0.0123	CcSEcCtD
Aclidinium—Infestation—Temozolomide—skin cancer	0.00972	0.0123	CcSEcCtD
Aclidinium—BCHE—nipple—skin cancer	0.0093	0.0437	CbGeAlD
Aclidinium—Sinusitis—Temozolomide—skin cancer	0.00912	0.0116	CcSEcCtD
Aclidinium—Infestation NOS—Fluorouracil—skin cancer	0.00896	0.0114	CcSEcCtD
Aclidinium—Infestation—Fluorouracil—skin cancer	0.00896	0.0114	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Imiquimod—skin cancer	0.00893	0.0113	CcSEcCtD
Aclidinium—Urinary tract disorder—Temozolomide—skin cancer	0.00862	0.0109	CcSEcCtD
Aclidinium—Cardiac failure—Docetaxel—skin cancer	0.0086	0.0109	CcSEcCtD
Aclidinium—Urethral disorder—Temozolomide—skin cancer	0.00855	0.0109	CcSEcCtD
Aclidinium—CHRM5—head—skin cancer	0.00851	0.04	CbGeAlD
Aclidinium—Sinusitis—Fluorouracil—skin cancer	0.0084	0.0107	CcSEcCtD
Aclidinium—Diarrhoea—Vemurafenib—skin cancer	0.0083	0.0105	CcSEcCtD
Aclidinium—Eye disorder—Temozolomide—skin cancer	0.00816	0.0104	CcSEcCtD
Aclidinium—Rhinitis—Fluorouracil—skin cancer	0.00806	0.0102	CcSEcCtD
Aclidinium—Mediastinal disorder—Temozolomide—skin cancer	0.00787	0.00999	CcSEcCtD
Aclidinium—Cough—Bleomycin—skin cancer	0.00786	0.00998	CcSEcCtD
Aclidinium—Vomiting—Vemurafenib—skin cancer	0.00771	0.0098	CcSEcCtD
Aclidinium—Headache—Vemurafenib—skin cancer	0.0076	0.00965	CcSEcCtD
Aclidinium—Nasopharyngitis—Docetaxel—skin cancer	0.0075	0.00953	CcSEcCtD
Aclidinium—Infection—Bleomycin—skin cancer	0.0073	0.00927	CcSEcCtD
Aclidinium—Vision blurred—Temozolomide—skin cancer	0.00716	0.00909	CcSEcCtD
Aclidinium—Diarrhoea—Imiquimod—skin cancer	0.00708	0.00899	CcSEcCtD
Aclidinium—Infection—Dactinomycin—skin cancer	0.00681	0.00865	CcSEcCtD
Aclidinium—Cough—Temozolomide—skin cancer	0.00663	0.00842	CcSEcCtD
Aclidinium—Vision blurred—Fluorouracil—skin cancer	0.0066	0.00838	CcSEcCtD
Aclidinium—Vomiting—Imiquimod—skin cancer	0.00658	0.00836	CcSEcCtD
Aclidinium—Headache—Imiquimod—skin cancer	0.00648	0.00823	CcSEcCtD
Aclidinium—Infestation NOS—Docetaxel—skin cancer	0.00647	0.00821	CcSEcCtD
Aclidinium—Infestation—Docetaxel—skin cancer	0.00647	0.00821	CcSEcCtD
Aclidinium—CHRM1—female reproductive system—skin cancer	0.00637	0.0299	CbGeAlD
Aclidinium—Dry mouth—Temozolomide—skin cancer	0.00633	0.00803	CcSEcCtD
Aclidinium—Infection—Temozolomide—skin cancer	0.00616	0.00782	CcSEcCtD
Aclidinium—Nervous system disorder—Temozolomide—skin cancer	0.00608	0.00772	CcSEcCtD
Aclidinium—BCHE—skin of body—skin cancer	0.00596	0.028	CbGeAlD
Aclidinium—CHRM2—head—skin cancer	0.00584	0.0275	CbGeAlD
Aclidinium—Rhinitis—Docetaxel—skin cancer	0.00582	0.00739	CcSEcCtD
Aclidinium—Urinary tract disorder—Docetaxel—skin cancer	0.00573	0.00728	CcSEcCtD
Aclidinium—CHRM3—female reproductive system—skin cancer	0.0057	0.0268	CbGeAlD
Aclidinium—Urethral disorder—Docetaxel—skin cancer	0.00569	0.00723	CcSEcCtD
Aclidinium—Infection—Fluorouracil—skin cancer	0.00568	0.00721	CcSEcCtD
Aclidinium—Nervous system disorder—Fluorouracil—skin cancer	0.0056	0.00712	CcSEcCtD
Aclidinium—Tachycardia—Fluorouracil—skin cancer	0.00558	0.00708	CcSEcCtD
Aclidinium—BCHE—mammalian vulva—skin cancer	0.00543	0.0255	CbGeAlD
Aclidinium—Eye disorder—Docetaxel—skin cancer	0.00542	0.00689	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Temozolomide—skin cancer	0.00535	0.0068	CcSEcCtD
Aclidinium—CHRM1—head—skin cancer	0.00532	0.025	CbGeAlD
Aclidinium—Mediastinal disorder—Docetaxel—skin cancer	0.00523	0.00664	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00493	0.00626	CcSEcCtD
Aclidinium—CHRM3—head—skin cancer	0.00476	0.0224	CbGeAlD
Aclidinium—Diarrhoea—Dactinomycin—skin cancer	0.00469	0.00596	CcSEcCtD
Aclidinium—Vomiting—Bleomycin—skin cancer	0.00467	0.00594	CcSEcCtD
Aclidinium—BCHE—female reproductive system—skin cancer	0.00465	0.0219	CbGeAlD
Aclidinium—Cough—Docetaxel—skin cancer	0.00441	0.0056	CcSEcCtD
Aclidinium—Vomiting—Dactinomycin—skin cancer	0.00436	0.00554	CcSEcCtD
Aclidinium—Diarrhoea—Temozolomide—skin cancer	0.00424	0.00539	CcSEcCtD
Aclidinium—Dry mouth—Docetaxel—skin cancer	0.00421	0.00534	CcSEcCtD
Aclidinium—Infection—Docetaxel—skin cancer	0.0041	0.0052	CcSEcCtD
Aclidinium—Nervous system disorder—Docetaxel—skin cancer	0.00404	0.00514	CcSEcCtD
Aclidinium—Tachycardia—Docetaxel—skin cancer	0.00402	0.00511	CcSEcCtD
Aclidinium—Vomiting—Temozolomide—skin cancer	0.00394	0.00501	CcSEcCtD
Aclidinium—Diarrhoea—Fluorouracil—skin cancer	0.00391	0.00496	CcSEcCtD
Aclidinium—BCHE—head—skin cancer	0.00389	0.0183	CbGeAlD
Aclidinium—Headache—Temozolomide—skin cancer	0.00388	0.00493	CcSEcCtD
Aclidinium—Vomiting—Fluorouracil—skin cancer	0.00363	0.00461	CcSEcCtD
Aclidinium—Headache—Fluorouracil—skin cancer	0.00358	0.00455	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Docetaxel—skin cancer	0.00356	0.00452	CcSEcCtD
Aclidinium—Diarrhoea—Docetaxel—skin cancer	0.00282	0.00358	CcSEcCtD
Aclidinium—BCHE—lymph node—skin cancer	0.00272	0.0128	CbGeAlD
Aclidinium—Vomiting—Docetaxel—skin cancer	0.00262	0.00333	CcSEcCtD
Aclidinium—Headache—Docetaxel—skin cancer	0.00258	0.00328	CcSEcCtD
